Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
National Cancer Institute (NCI)
Joyce F Liu; Mark F Brady; Ursula A Matulonis; Austin Miller; Elise C Kohn; Elizabeth M Swisher; David Cella; William P Tew; Noelle G Cloven; Carolyn Y Muller; David P Bender; Richard G Moore; David P Michelin; Steven E Waggoner; Melissa A Geller; Keiichi Fujiwara; Stacy D D'Andre; Michael Carney; Angeles Alvarez Secord; Katherine M Moxley; Michael A Bookman
NRG Oncology; Clinical Trial Development Division; Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY. ; NRG Oncology; Clinical Trial Development Division; Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY.